[go: up one dir, main page]

IL138994A - 2-methylpropionic acid derivatives and medicinal compositions containing the same - Google Patents

2-methylpropionic acid derivatives and medicinal compositions containing the same

Info

Publication number
IL138994A
IL138994A IL13899499A IL13899499A IL138994A IL 138994 A IL138994 A IL 138994A IL 13899499 A IL13899499 A IL 13899499A IL 13899499 A IL13899499 A IL 13899499A IL 138994 A IL138994 A IL 138994A
Authority
IL
Israel
Prior art keywords
ethyl
group
carbon atom
methylpropionic acid
diseases caused
Prior art date
Application number
IL13899499A
Other languages
English (en)
Other versions
IL138994A0 (en
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of IL138994A0 publication Critical patent/IL138994A0/xx
Publication of IL138994A publication Critical patent/IL138994A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/18Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to carbon atoms of six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13899499A 1998-04-14 1999-04-07 2-methylpropionic acid derivatives and medicinal compositions containing the same IL138994A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14202898 1998-04-14
PCT/JP1999/001836 WO1999052856A1 (en) 1998-04-14 1999-04-07 2-methylpropionic acid derivatives and medicinal compositions containing the same

Publications (2)

Publication Number Publication Date
IL138994A0 IL138994A0 (en) 2001-11-25
IL138994A true IL138994A (en) 2004-02-19

Family

ID=15305697

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13899499A IL138994A (en) 1998-04-14 1999-04-07 2-methylpropionic acid derivatives and medicinal compositions containing the same

Country Status (19)

Country Link
US (2) US6696489B1 (es)
EP (1) EP1072583B1 (es)
JP (1) JP4212771B2 (es)
KR (1) KR100576131B1 (es)
AR (1) AR015761A1 (es)
AT (1) ATE275126T1 (es)
AU (1) AU768217C (es)
CA (1) CA2328348C (es)
CO (1) CO5021214A1 (es)
DE (1) DE69919860T2 (es)
ES (1) ES2228028T3 (es)
IL (1) IL138994A (es)
MY (1) MY122400A (es)
NO (1) NO20005164L (es)
NZ (1) NZ507486A (es)
PE (1) PE20000423A1 (es)
TW (1) TW581754B (es)
WO (1) WO1999052856A1 (es)
ZA (1) ZA200005589B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1146035T3 (da) * 1999-01-21 2006-03-27 Kissei Pharmaceutical Krystalpolymorfi af aminoethylphenoxyeddikesyrederivat
JP3815496B2 (ja) 2002-11-07 2006-08-30 アステラス製薬株式会社 酢酸アニリド誘導体を有効成分とする過活動膀胱治療剤
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine
AU2004212381B2 (en) * 2003-02-14 2008-08-21 Kissei Pharmaceutical Co., Ltd. Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof
ITMI20061581A1 (it) * 2006-08-04 2008-02-05 Univ Bari Ligandi del recettore beta-3 adrenergico e loro uso in terapia
TWI478712B (zh) 2008-09-30 2015-04-01 Astellas Pharma Inc 釋控性醫藥組成物
JP5849947B2 (ja) 2010-03-29 2016-02-03 アステラス製薬株式会社 放出制御医薬組成物
US12097189B1 (en) 2024-02-09 2024-09-24 Astellas Pharma Inc. Pharmaceutical composition for modified release

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146638A (en) * 1976-02-17 1979-03-27 Boehringer Ingelheim Gmbh N-(3-phenoxy-2-hydroxy-propyl)-n-(2-phenyl-2-hydroxy-ethyl)-amines
ATE1994T1 (de) * 1979-06-16 1982-12-15 Beecham Group Plc Aethanamin-derivate, ihre herstellung und verwendung in pharmazeutischen zusammensetzungen.
FR2750668B1 (fr) 1996-07-03 1998-11-20 Savard Franck Dispositif de tension et de guidage d'une chaine pour un changement de vitesses de velo
AU4320297A (en) * 1996-09-26 1998-04-17 Kissei Pharmaceutical Co. Ltd. 2-amino-1-(4-hydroxy-2-methylphenyl)propanol derivatives
ID24062A (id) * 1997-07-25 2000-07-06 Kissei Pharmaceutical Turunan-turunan asam aminoetilfenoksiasetat dan obat untuk mengurangi nyeri dan membantu penyingkiran dalam litiasis saluran air kencing
PL341221A1 (en) * 1997-12-18 2001-03-26 Kissei Pharmaceutical Derivatives of phenylaminoalkyl carboxylic acid and pharmacological compositions containing them

Also Published As

Publication number Publication date
EP1072583A4 (en) 2001-12-05
WO1999052856A1 (en) 1999-10-21
PE20000423A1 (es) 2000-05-22
ZA200005589B (en) 2002-01-11
TW581754B (en) 2004-04-01
IL138994A0 (en) 2001-11-25
ATE275126T1 (de) 2004-09-15
AU3166199A (en) 1999-11-01
CO5021214A1 (es) 2001-03-27
JP4212771B2 (ja) 2009-01-21
ES2228028T3 (es) 2005-04-01
KR100576131B1 (ko) 2006-05-03
CA2328348A1 (en) 1999-10-21
AR015761A1 (es) 2001-05-16
CA2328348C (en) 2009-03-03
KR20010042683A (ko) 2001-05-25
NO20005164L (no) 2000-12-12
DE69919860T2 (de) 2005-08-25
AU768217C (en) 2005-04-21
DE69919860D1 (de) 2004-10-07
AU768217B2 (en) 2003-12-04
EP1072583A1 (en) 2001-01-31
EP1072583B1 (en) 2004-09-01
US20030166719A1 (en) 2003-09-04
NO20005164D0 (no) 2000-10-13
MY122400A (en) 2006-04-29
US6790865B2 (en) 2004-09-14
US6696489B1 (en) 2004-02-24
NZ507486A (en) 2003-03-28

Similar Documents

Publication Publication Date Title
CA2336853C (en) Phenoxyacetic acid derivatives and medicinal compositions containing the same
FI88030B (fi) Foerfarande foer framstaellning av terapeutiskt aktiva fenoxiaettiksyraderivat
JPWO2000002846A1 (ja) フェノキシ酢酸誘導体および当該誘導体を含有する医薬組成物
CA2315235C (en) Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same
EP1072583B1 (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same
CA2298493C (en) Aminoethylphenoxyacetic acid derivatives and drugs for pain remission and calculi removal promotion in urinary lithiasis
WO1997030023A1 (en) 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives
JPWO1999052856A1 (ja) 2−メチルプロピオン酸誘導体および当該誘導体を含有する医薬組成物
JPWO1999005090A1 (ja) アミノエチルフェノキシ酢酸誘導体および尿路結石症の疼痛緩解および排石促進剤
WO1997035835A1 (en) 3,4-disubstituted phenylethanolaminotetralincarboxylate derivatives
MXPA00000869A (es) Derivados de acido aminoetilfenoxiacetico y farmacos para la remision del dolor y la promocion para la eliminacion de calculos en la litiasis urinaria
MXPA01000239A (es) Derivados de acido fenoxiacetico y composiciones medicinales que los contienen

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees